Skip to content
Therapy But Better – Lifestyle
Author:
Curium
Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan
June 11, 2026
Curium Announces a Strategic Investment of Over €32 million in Saclay, France
June 1, 2026